Liver cancer
Conditions
Interventions
Case series:None
Sponsors
Zhongshan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Adults, aged 18 and above, under 80 years old; (2) Diagnosed as liver tumor by imaging (abdominal enhanced MRI) and serology (tumor index, liver function) (including primary malignant tumor, secondary malignant tumor, various benign tumors); (3) The American Society of Anesthesiologists (ASA) is graded 1-2, and histopathological diagnosis can be obtained by surgery; (4) Patients voluntarily participate in the study, sign the consent form, have good compliance, and obey the follow-up, and are willing and able to comply with the protocol during the study
Exclusion criteria
Exclusion criteria: (1) Surgical treatment cannot be carried out (such as liver insufficiency, etc.), and pathological histological diagnosis cannot be obtained; (2) Those with peripheral nervous system disorders or a history of obvious mental disorders and central nervous system disorders; (3) Women with positive serum pregnancy test or lactation; (4) Previous history of liver surgery, or liver interventional therapy, radiation therapy, or systemic chemotherapy, immunotargeted therapy, etc.; (5) Have a history of organ transplantation (including autologous bone marrow transplantation and peripheral stem cell transplantation).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor tissue RNA-seq analysis of differential gene expression; | — |
Countries
China
Contacts
Public ContactShi Guoming
Zhongshan Hospital Affiliated to Fudan University
Outcome results
None listed